Targeting PGC-1α as therapeutic strategy against sickle cell disease
Aug. 26, 2024
Recent studies have shown that up-regulation of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) was able to induce fetal hemoglobin synthesis in human primary erythroblasts.